MedPath

Physiotherapy in Stress Urinary Incontinence

Not Applicable
Completed
Conditions
Urinary Incontinence,Stress
Interventions
Other: functional magnetic stimulation
Other: pelvic floor muscle training program
Registration Number
NCT05721807
Lead Sponsor
Lithuanian Sports University
Brief Summary

The goal of this randomized controlled trial is to evaluate and compare the effects of functional magnetic stimulation and pelvic floor muscle training on pelvic floor muscle function, urinary incontinence symptoms and quality of life in women with stress urinary incontinence. The main questions it aims to answer are:

* What is the effect of functional magnetic stimulation on pelvic floor muscle function, symptoms of urinary incontinence and quality of life in women with stress urinary incontinence?

* What is the effect of pelvic floor muscle training program on pelvic floor muscle function, symptoms of urinary incontinence and quality of life in women with stress urinary incontinence?

* Which intervention is more effective - functional magnetic stimulation or pelvic floor muscle training program?

Participants will be evaluated before and after the intervention with the following methods:

* International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF);

* Incontinence Impact Questionnaire-Short Form (IIQ-7);

* Pelvic floor muscle strength and endurance will be assessed with a "Pelvexiser" perineometer.

Detailed Description

The study was performed in the period of 07/21/2021-30/10/2021. The study included 48 women 29-49 years old who have complained of stress urinary incontinence for at least 4 weeks, who gave birth and signed the consent form. Women complaining of vaginismus, suffering from urinary tract infection, cancer, epilepsy or skin conditions with implanted pacemakers, metal implants and pregnant women were excluded from the study. Study participants were randomly divided into two groups: the I group (n=24), in which participants underwent functional magnetic stimulation (FMS) and the II group (n=24) in which subjects received pelvic floor muscle training (PFMT) program. Participants were evaluated before the intervention and repeated after 6 weeks. Subjects responded to a general questionnaire before the intervention, before and after the intervention, the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and Incontinence Impact Questionnaire-Short Form (IIQ-7) were used to assess the symptoms of urinary incontinence and their impact on quality of life. Pelvic floor muscle strength and endurance were assessed with a "Pelvexiser" perineometer. Statistical analysis was performed by IBM SPSS Statistics 26.0 and Microsoft Excel software 365.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
48
Inclusion Criteria
  • complains of stress incontinence for at least 4 weeks;
  • women who have given birth.
Exclusion Criteria
  • pregnancy;
  • vaginism;
  • urinal infection;
  • oncological disorders;
  • epilepsy;
  • skin problems;
  • if they had an implanted heart pacemaker, metal implants.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
functional magnetic stimulationfunctional magnetic stimulationfunctional magnetic stimulation for stress urinary incontinence
pelvic floor muscle training programpelvic floor muscle training programexercise program for pelvic floor muscle
Primary Outcome Measures
NameTimeMethod
PerineometryChange from Baseline Perineometry at 6 weeks

The strength and endurance of the subjects' pelvic floor muscles was assessed with a Pelvexiser perineometer (Wolfram Haboeck Co., Austria). This apparatus has been scientifically proven as an objective method of assessing the function of the pelvic floor muscles and an effective exerciser for strengthening the pelvic floor muscles, which is why it is often used in the presence of for urinary incontinence problems. The Pelvexiser can provide varying resistance to the pelvic floor muscles and provide real-time feedback on pelvic floor muscle contractions and changes (Chitra et al., 2010).

IIQ-7 -Incontinence Impact QuestionnaireChange from Baseline Incontinence Impact Questionnaire scores at 6 weeks

The IIQ-7 questionnaire is designed to assess the impact of urinary incontinence on quality of life. The questionnaire consists of seven questions, which can be answered to find out the impact of urinary incontinence on all areas of life: physical activity, traveling, social activity, relationships, emotional state. Each question is evaluated from 0 to 3 points. The higher the score, the worse the quality of life. The maximum number of collected points is 100, the minimum is 0. \<50 points is considered a good quality of life, 50-70 points is an average quality of life, \>70 points is a poor quality of life.

Urinary incontinence symptoms and quality of life (International Consultation on Incontinence Questionnaire)Change from Baseline Urinary Incontinence symptoms at 6 weeks

ICIQ - SF - International Consultation on Incontinence Questionnaire - Short Form is intended to subjectively evaluate the symptoms of urinary incontinence in a woman or man and the impact of those symptoms on the quality of life. The questionnaire consists of four questions. The first two questions assess the symptoms of urinary incontinence experienced, the third question describes quality of life and the fourth question determines which type of incontinence the person has. The scores of the first three questions are summed up, the maximum number of points collected is 21, the minimum is 0. Depending on the number of points collected, the severity of urinary incontinence symptoms is assessed: no urinary incontinence symptoms (0 points), mild urinary incontinence symptoms (1 - 5 points), moderate incontinence symptoms (score 6-12), severe incontinence symptoms (score 13-18) and very severe incontinence symptoms (19-21).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Lithuanian Sports University

🇱🇹

Kaunas, Lithuania

© Copyright 2025. All Rights Reserved by MedPath